Guduchi (Tinospora cordifolia) Stem: Nighantu Review and API-Based Standardisation of Market vs Authenticated Samples

Guduchi (Tinospora cordifolia (Willd.) Miers, family Menispermaceae) is one of the most frequently used drugs in Ayurvedic practice — described as Amrita in the classics, a rasayana and jwaraghna dravya, and part of the Vayasthapana group in the Charaka Samhita. Demand rose sharply in recent years, and with it the risk of substitution with the related species Tinospora sinensis, of stems collected from any host tree, and of poorly dried or contaminated raw material in local raw-drug shops.

This project has two parts. Part A is a structured classical review: the rasa, guna, virya, vipaka, prabhava, karma and indications of Guduchi are extracted from the Charaka and Sushruta Samhitas and from major Nighantus (Dhanvantari, Bhavaprakasha, Raja Nighantu) into a comparison table, including the classical preference for Guduchi growing on neem. Part B is a laboratory standardisation study comparing one authenticated sample with three market samples, using the Ayurvedic Pharmacopoeia of India (API) monograph: macroscopy, transverse-section microscopy, powder microscopy, foreign matter, loss on drying, total and acid-insoluble ash, alcohol- and water-soluble extractive values, preliminary phytochemical screening and an HPTLC fingerprint.

The result is a documented answer to a practical question every dispensary faces — does the Guduchi we buy meet pharmacopoeial standards? — alongside a clear record of what the classical texts actually say about the drug.

Abstract

The study combines a classical literature review of Guduchi with a comparative pharmacognostic and physicochemical evaluation of four stem samples: one authenticated sample collected from a Tinospora cordifolia plant growing on Azadirachta indica in the college herbal garden, and three samples purchased from raw-drug shops. Each sample will be tested as per the API monograph, and HPTLC fingerprints will be compared. Quantitative parameters will be analysed by one-way ANOVA with post-hoc comparison.

Introduction

The efficacy and safety of an Ayurvedic formulation depend first on the identity and quality of its raw drug. The classics already recognised this — Guduchi collected from neem was considered superior, and fresh Guduchi was preferred for certain preparations. Today, quality is assessed with the API monographs published by the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). Student-level training in Dravyaguna often covers these tests theoretically; this project applies them to real market samples.

Literature gap

Several published studies report substitution and quality variation in Guduchi sold in Indian markets, but most either review classical literature or test samples, rarely both. Few student studies link the classical description (appearance, taste, texture) with measurable pharmacopoeial parameters, and very few present statistics.

Proposed work

• Compile classical references into a structured table and summarise points of agreement and difference across texts.
• Authenticate a reference sample with a herbarium voucher.
• Evaluate four samples by API parameters in triplicate.
• Develop an HPTLC fingerprint and compare band patterns.
• Compare samples statistically and against API limits.

Feasibility

• Technical: microscopy and physicochemical tests are available in the Dravyaguna and pharmacy labs; HPTLC is available through the college's drug-testing laboratory or a nearby approved lab.
• Economic: market samples, solvents and HPTLC plates cost roughly ₹5,000–8,000; HPTLC analysis charges, if outsourced, are the largest item.
• Ethical: no human or animal subjects.

Guduchi is used daily in dispensaries and pharmacies as stem powder, kwatha and satva, often bought from local raw-drug shops without testing. Market samples may be substituted with Tinospora sinensis, collected from unknown hosts, poorly dried, or mixed with foreign matter and soil, any of which changes the drug's quality and possibly its action. At the same time, students learn the classical properties of Guduchi and its pharmacopoeial standards as separate topics, without seeing how they connect.

There is a need for a small, rigorous study that documents the classical description of Guduchi from primary texts and tests actual market samples against API standards, using an authenticated sample as reference, so that the quality gap — if any — is measured rather than assumed, and a simple quality-check protocol can be recommended to the college pharmacy.

In scope

• Classical review of Guduchi from Samhitas and Nighantus available in the college library (Sanskrit text with standard Hindi/English commentaries).
• Four stem samples: one authenticated, three from different raw-drug shops in the city.
• API monograph tests, phytochemical screening and HPTLC fingerprinting.
• Descriptive and inferential statistics.

Out of scope

• Pharmacological or clinical studies of Guduchi.
• Heavy-metal, pesticide-residue, aflatoxin and microbial-load testing (listed as future work; needs an accredited lab).
• Quantification of individual markers by validated HPLC.
• DNA barcoding of samples.

Study design: combined literary review and laboratory-based comparative analytical study.

Setting: Department of Dravyaguna, a BAMS college (fictional: Sri Dhanvantari Ayurveda Mahavidyalaya); HPTLC at the college's drug-testing laboratory or an approved external lab.

Part A — Classical review: texts searched: Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, Dhanvantari Nighantu, Bhavaprakasha Nighantu, Raja Nighantu, Kaiyadeva Nighantu. A data-extraction template records synonyms (paryaya), rasa-panchaka, karma, rogaghnata, useful part, dose, preparations and special notes. Entries are verified against the Sanskrit shloka, not only the commentary.

Part B — Samples: one authenticated stem sample collected from a mature plant growing on neem, authenticated by a botanist with voucher specimen; three market samples bought anonymously from three raw-drug shops. All stems shade-dried, cut and powdered (sieve no. 60).

Sample size justification: four samples × three replicates per test (n = 3) gives 12 observations per parameter, adequate for one-way ANOVA (df = 3, 8) and consistent with pharmacopoeial practice of triplicate determination.

Inclusion / exclusion: market samples must be labelled or sold as Guduchi/Giloy stem; samples visibly mouldy are excluded but recorded as a finding.

Tests (as per API): macroscopy (colour, fracture, surface, taste); transverse section and powder microscopy; foreign matter; loss on drying at 105 °C; total ash; acid-insoluble ash; alcohol-soluble and water-soluble extractive values; preliminary phytochemical tests (alkaloids, glycosides, saponins, tannins, flavonoids, steroids); TLC/HPTLC of methanolic extract on silica gel 60 F254, scanned at 254 and 366 nm and after derivatisation.

Statistical analysis: mean ± SD for each parameter; one-way ANOVA with Tukey's post-hoc test in SPSS (Excel for tables); p < 0.05. Compliance with API limits reported as pass/fail.

Ethics: no human or animal participants; no IEC approval needed. Market samples are identified only as M1–M3; shop names are not published.